Rollins John Woodson has filed 4 insider transactions across 1 company since February 2026.
Most recent transaction: a transaction of 13029 shares of 20/20 Biolabs, Inc. ($AIDX) on February 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | 20/20 Biolabs, Inc. | $AIDX | Rollins John Woodson | Director | C | Common Stock | 13029 | $0.00 | 24,140.0000 | 0 | 117.26% | 0.00% |
| Feb. 19, 2026 | 20/20 Biolabs, Inc. | $AIDX | Rollins John Woodson | Director | C | Common Stock | 6135 | $0.00 | 30,275.0000 | 0 | 25.41% | 0.00% |
| Feb. 19, 2026 | 20/20 Biolabs, Inc. | $AIDX | Rollins John Woodson | Director | C | Series A Preferred Stock | 13029 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 19, 2026 | 20/20 Biolabs, Inc. | $AIDX | Rollins John Woodson | Director | C | Series A-2 Preferred Stock | 6135 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |